論文發表 (2024 JCR)

1. Tsan-Chi Chen, Wan-Lin Wu, Shu-Wen Chang. Persistent loss of membrane-associated MUC4 reprograms physiological functions in corneal epithelial cells via MAPK-dependent cascade. Sci Rep. 2026 May 27. doi: 10.1038/s41598-026-54944-9. [IF: 3.9; SCI 25/136 (19.6%) in Multidisciplinary Sciences]
2. Shu-Wen Chang, Shiuh-Liang Hsu, Chih-Chien Hsu. Real-world practice patterns for dry eye diagnosis: a multicenter observational study in Taiwan. Jpn J Ophthalmol. 2025 May;69(3):343-350. doi: 10.1007/s10384-025-01175-6. Epub 2025 Mar 8. [IF: 1.9; SCI 47/98 (48.0%) in Ophthalmology]
3. Wan-Lin Wu, Shu-Wen Chang. Characterization of Individuals with High-Frequency Artificial Tear Supplement Use. J Clin Med. 2025 Apr 15;14(8):2694. doi: 10.3390/jcm14082694. [IF: 2.9; SCI 65/332 (19.6%) in Medicine, General & Internal]
4. Wei-Ting Ho, Jung-Shen Chang, Chia-Jen Lei, Tsan-Chi Chen, Jia-Kang Wang, Shu-Wen Chang, Muh-Hwa Yang, Tzuu-Shuh Jou, I-Jong Wang. ROCK Inhibitor Enhances Resilience Against Metabolic Stress Through Increasing Bioenergetic Capacity in Corneal Endothelial Cells. Invest Ophthalmol Vis Sci. 2025 Jan 2; 66(1):51. doi: 10.1167/iovs.66.1.51. [IF: 4.7; SCI 9/98 (9.2%) in Ophthalmology]
5. Tsan-Chi Chen, Shu-Wen Chang*. Non-lethal exposure to short-wavelength light-emitting diodes modulates tight-junction structure in human corneal epithelial cells via cAMP-dependent signaling. J Photochem Photobiol B. 2024 Feb 15:252:112869. doi: 10.1016/j.jphotobiol.2024.112869. [IF: 3.7; SCI 16/79 (20.3%) in Biophysics]
6. Po-Jen Shih, Hua-Ju Shih, I-Jong Wang, Shu-Wen Chang. The extraction and application of antisymmetric characteristics of the cornea during air-puff perturbations. Comput Biol Med. 2024 Jan:168:107804. doi: 10.1016/j.compbiomed.2023.107804. Epub 2023 Dec 4. [IF: 6.3; SCI 7/107 (6.5%) in Biolocy]
7. Wan-Lin Wu, Shu-Wen Chang*. Effects of cyclosporine on steroid-refractory dry eyes. Taiwan J Ophthalmol. 2023 Mar 24;13(3):306-316. doi: 10.4103/tjo.TJO-D-22-00165. eCollection 2023 Jul-Sep. [IF: 1.2; SCI 69/98 (69.4%) in Ophthalmology]
8. Pei-Yuan Su, Jia-Kang Wang, Shu-Wen Chang. Computed Tomography Morphology of Affected versus Unaffected Sides in Patients with Unilateral Primary Acquired Nasolacrimal Duct Obstruction. J Clin Med. 2023 Jan 1;12(1):340. doi: 10.3390/jcm12010340. [IF: 2.9; SCI 65/332 (19.6%) in Medicine, General & Internal]
9. Ju-Yeh Yang, Yen-Wen Wu, Wenpo Chuang, Tzu-Chun Lin, Shu-Wen Chang, Shou-Hsia Cheng, Raymond N. Kuo. An Integrated Community-Based Blood Pressure Telemonitoring Program – A Population-Based Observational Study. Acta Cardiol Sin. 2022 Sep;38(5):612-622. doi: 10.6515/ACS.202209_38(5).20220330A. [IF: 1.8; SCI 137/230 (59.6%) in Cardiac & Cardiovascular Systems]
10. Wei-Ting Ho, Chiung-Yi Chiu, Shu-Wen Chang*. Low ambient temperature correlates with the severity of dry eye symptoms. Taiwan J Ophthalmol. 2022 Apr-Jun;12(2):191-197. doi: 10.4103/tjo.tjo_25_21.[IF: 1.2; SCI 69/98 (69.4%) in Ophthalmology]
11. Wei-Ting Ho, Jung-Shen Chang, Tsan-Chi Chen, Jia-Kang Wang, Shu-Wen Chang, Muh-Hwa Yang, Tzuu-Shuh Jou*, I-Jong Wang*. Inhibition of Rho-associated protein kinase activity enhances oxidative phosphorylation to support corneal endothelial cell migration. FASEB J. 2022 Jul ;36(7):e22397. doi: 10.1096/fj.202101442RR. [IF: 4.2; SCI 17/107 (15.9%) in Biology]
12. Shu-Wen Chang*, Wan-Lin Wu. Association between Dry Eye Parameters Depends on Tear Components. J Clin Med. 2022 May 28;11(11):3056. doi: 10.3390/jcm11113056.[IF: 2.9; SCI 65/332 (19.6%) in Medicine, General & Internal]
13. Yi-Ching Chu, Tzu-Lun Huang, Pei-Yao Chang, Wei-Ting Ho, Yung-Ray Hsu, Shu-Wen Chang, Jia-Kang Wang. Predictability of 6 Intraocular Lens Power Calculation Formulas in People With Very High Myopia. Front Med (Lausanne). 2022; 9: 762761. [IF: 3.0; SCI 61/332 (18.4%) in Medicine, General & Internal]
14. Wan-Lin Wu, Shu-Wen Chang*. Dermatochalasis Aggravates Meibomian Gland Dysfunction Related Dry Eyes. J Clin Med. 2022 Apr 23;11(9):2379. doi: 10.3390/jcm11092379. [IF: 2.9; SCI 65/332 (19.6%) in Medicine, General & Internal]
15. Tsan-Chi Chen, Shu-Wen Chang*. Repeated cell sorting ensures the homogeneity of ocular cell populations expressing a transgenic protein. PLoS ONE 2022; 17(3):e0265183. doi: 10.1371/journal.pone.0265183. eCollection 2022. [IF: 2.6; SCI 44/135 (32.6%) in Multidisciplinary Sciences]
16. Tsan-Chi Chen, Shu-Wen Chang*. Moxifloxacin induces random migration in human corneal fibroblasts via the protein kinase C epsilon/zonula occludens-1 signaling pathway. Eur. J. Pharmacol. 2021; 910;910:174414. doi: 10.1016/j.ejphar.2021.174414 [IF: 4.7; SCI 54/352 (15.3%) in Pharmacology & Pharmacy]
17. Hsin-Yu Weng, Wei-Ting Ho, Chiung-Yi Chiu, Tzu-Yun Tsai, Shu-Wen Chan*. Characteristics of tear film lipid layer in young dry eye patients. J Formos Med Assoc. 2021 Jul;120(7):1478-1484. doi: 10.1016/j.jfma.2020.10.028.?Epub 2020 Nov 23. [IF: 2.5; SCI 74/332 (22.3%) in Medicine, General & Internal]
18. Ling-Uei Wang, Fang-Ting Chen, Yun-Ju Chen, Jia-Kang Wang, Shu-Wen Chang, Yung-Ray Hsu. Clinical and Epidemiological Profiles of Retinal Vasculitis in Northern Taiwan. Ocul Immunol Inflamm. 2020 Sep;1-8. doi: 10.1080/09273948.2020.1811352. [IF: 2.0; SCI 44/98 (44.9%) in Ophthalmology]
19. Pei-Yao Chang, Jiun-Yi Wang, Jia-Kang Wang, Shih-Cheng Yeh, Shu-Wen Chang. Asymmetry analysis of optical coherence tomography angiography macular perfusion density measurements in preperimetric and perimetric glaucoma. Scientific Reports 2020; 10(1):14781. doi: 10.1038/s41598-020-71757-6. [IF: 3.9; SCI 25/135 (18.5%) in Multidisciplinary Sciences]
20. Tai-Yuan Su, Shu-Wen Chang*. Normalized ocular surface temperature models for tear film characteristics and dry eye disease evaluation. Ocular Surface 2021 Jan:19::74-82. doi: 10.1016/j.jtos.2020.04.002. Epub 2020 Apr 13. [IF: 5.6; SCI 6/98 (6.1%) in Ophthalmology]
21. Yao-Lin Liu, Chia-Jung Lee, Jao-Shwann Liang, Shu-Wen Chang, Tzu-Hsun Tsai. Refinement strategies in photoscreening for the detection of amblyopia risk factors in 12-to-24-month-old children. J Formos Med Assoc. 2021 Jan;120 (1 Pt 1):137-144. doi: 10.1016/j.jfma.2020.03.003. [IF: 2.5; SCI 74/332 (22.3%) in Medicine, General & Internal]
22. Shu-Wen Chang,* Wan-Lin Wu. Age Affects Intraocular Lens Attributes Preference in Cataract Surgery. Taiwan Journal of Ophthalmology.?2021 Apr 24;11(3):280-286. doi: 10.4103/tjo.tjo_20_20. eCollection 2021 Jul-Sep. [IF: 1.2; SCI 69/98 (70.4%) in Ophthalmology]
23. Pei-Yao Chang, Jia-Kang Wang, Hsin-Yu Weng, Shu-Wen Chang. Cataract surgery reduces intraocular pressure but not posture-induced intraocular pressure changes in patients with angle-closure glaucoma. Scientific Reports 2019; 9:14116. [IF: 3.9; SCI 25/135 (18.5%) in Multidisciplinary Sciences]
24. Tsan-Chi Chen, Wei-Ting Ho, Chien-Hsueh Lai, Shu-Wen Chang*. Mitomycin C modulates intracellular matrix metalloproteinase-9 expression and affects corneal fibroblast migration. Eur. J. Pharmacol. 2019; 865:172752 [IF: 4.7; SCI 54/352 (15.3%) in Pharmacology & Pharmacy]
25. Wei-Ting Ho, Jung-Shen Chang, San-Fang Chou, Wei-Lun Hwang, Po-Jen Shih, Shu-Wen Chang, Muh-Hwa Yang, Tzuu-Shuh Jou,I-Jong Wang. Targeting non-muscle myosin II promotes corneal endothelial migration through regulating lamellipodial dynamics. J Mol Med (Berl) 2019 Sep; 97(9):1345-1357. [IF: 4.2; SCI 40/191 (20.9%) in Genetics & Heredity]
26. Po-Ting Yeh, Lu-Chun Wang, Shu-Wen Chang, Wei-Shiung Yang, Chung-May Yang, Chang-Hao Yang*. Effect of Fenofibrate on the Expression of Inflammatory Mediators in a Diabetic Rat Model. Curr Eye Res. 2019 Jun 3:1-12. [IF: 2.0; SCI 44/98 (44.9%) in Ophthalmology]
27. Wei-Ting Ho, Jung-Shen Chang, Tsan-Chi Chen, San-Fang Chou, I-Jong Wang, Shu-Wen Chang*. Evaluation of patent blue as the vital dye in the animal model of Descemet Membrane Endothelial Keratoplasty. Cornea. 2019 Mar; 38(3):360-363. [IF: 2.1; SCI 40/98 (40.8%) in Ophthalmology]
28. Po-Ting Yeh, Yu-Hsun Huang, Shu-Wen Chang, Lu-Chun Wang, Chung-May Yang, Wei-Shiung Yang, Chung-Wu Lin, Chang-Hao Yang*. Cilostazol Attenuates Retinal Oxidative Stress and Inflammation in a Streptozotocin-Induced Diabetic Animal Model. Curr Eye Res. 2019 Mar; 44(3):294-302. [IF: 2.0; SCI 44/98 (44.9%) in Ophthalmology]
29. Pei-Yao Chang, Jiun-Yi Wang, Shu-Wen Chang, Yu-Chia Chang. Changes in Ocular Hypotensive Drug Usage for Glaucoma Treatment After Cataract Surgery: A Nationwide Population-based Study in Taiwan. J Glaucoma. 2018 Jul; 27(7):600-605. [IF: 1.8 ; SCI 51/98 (52.0%) in Ophthalmology]
30. Yung-Ray Hsu, Shu-Wen Chang, Yu-Cheng Lin, Chang-Hao Yang. MicroRNA-146a Alleviates Experimental Autoimmune Anterior Uveitis in the Eyes of Lewis Rats. Mediators Inflamm. 2017 (Published online 2017 Dec 24) [IF: 4.2; SCI 16/183 (33.3%) in Immunology]
31. Tsan-Chi Chen, Shu-Wen Chang*. Moxifloxacin Modulated TGF-β1-Related Interleukin-12 Secretion in Corneal Fibroblasts. Invest. Ophthalmol. Vis. Sci. 2017 Nov; 58(13):5692-5702. [IF: 4.7; SCI 9/98 (9.2%) in Ophthalmology]
32. Tai-Yuan Su, Wei-Ting Ho, Shu-Chiung Chiang, Chien-Yi Lu, Huihua Kenny Chiang, Shu-Wen Chang*. Infrared thermography in the evaluation of meibomian gland dysfunction. J Formos Med Assoc. 2017 July; 116(7):554-559 [IF: 2.5; SCI 74/332 (22.3%) in Medicine, General & Internal]
33. Tzu-Lun Huang, Yao-Tseng Wen, Chung-Hsing Chang, Shu-Wen Chang, Kuan-Hung Lin, Rong-Kung Tsai. Early Methylprednisolone Treatment Can Stabilize the Blood-Optic Nerve Barrier in a Rat Model of Anterior Ischemic Optic Neuropathy (rAION). Invest. Ophthalmol. Vis. Sci. 2017 Mar 1; 58(3):1628-36. [IF: 4.7; SCI 9/98 (9.2%) in Ophthalmology]
34. Pei-Yao Chang, Chi-Yang Lian, Jia-Kang Wang, Pei-Yuan Su, Jiun-Yi Wang, Shu-Wen Chang*. Surgical approach affects intraocular lens decentration. J Formos Med Assoc. 2017 Mar; 116(3):177-184. [IF: 2.5; SCI 74/332 (22.3%) in Medicine, General & Internal]
35. Jia-Kang Wang, Shu-Wen Chang. Refractive results of phacoemulsification in vitrectomized patients. Int. Ophthalmol. 2017 Jun; 37(3):673-681 [IF: 1.4; SCI 61/98 (62.2%) in Ophthalmology]
36. Wei-Ting Ho, Chien-Chia Su, Jung-Shen Chang, Shu-Wen Chang, Fung-Rong Hu, Tzuu-Shuh Jou, I-Jong Wang. In Vitro and In Vivo Models to Study Corneal Endothelial-mesenchymal Transition. J Vis Exp. 2016 Aug 20;(114) [IF: 1.0; SCI 85/135 (63.0%) in Multidisciplinary Science]
37. Yung-Ray Hsu, Shu-Wen Chang, Chang-Hao Yang, Yi-An Lee, Tzu-Yun Kao. Expression Profile of Cationic Amino Acid Transporters in Rats with Endotoxin-Induced Uveitis. Mediators Inflamm. 2016 (Published online 2016 Jun 16) [IF: 4.2; SCI 16/183 (33.3%) in Immunology]
38. Tzu-Lun Huang, Yao-Tseng Wen, Chung-Hsing Chang, Shu-Wen Chang, Kung-Hung Lin, Rong-Kung Tsai. Efficacy of Intravitreal Injections of Triamcinolone Acetonide in a Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy. Invest. Ophthalmol. Vis. Sci. 2016 Apr; 57(4):1878-84. [IF: 4.7; SCI 9/98 (9.2%) in Ophthalmology]
39. Tsan-Chi Chen, Tzu-Yun Tsai, Shu-Wen Chang*. Molecular Mechanism of Fluoroquinolone Modulation on Corneal Fibroblast Motility. Exp. Eye Res. 2016 Apr; 145:10-6 [IF: 2.7; SCI 26/98 (26.5%) in Ophthalmology]
40. Shu-Wen Chang*, Andy. Y. Lo, Po-Fang Su. Anterior Segment Biometry Changes with Cycloplegia in Myopic Adults. Optom Vis Sci. 2016 Jan;93(1):12-8. [IF: 1.8; SCI 51/98 (52.0%) in Ophthalmology]
41. Tai-Yuan Su, Wei-Ting Ho, Shu-Wen Chang, Huihua Kenny Chiang. Thermographic evaluation of tear film break-up time to study tear film stability. Int. J. Therm. Sci. 2016 Jan; 99:36-40. [IF: 5.0; SCI 28/182 (15.4%) in Engineering, Mechanical]
42. Yung-Ray Hsu, Shu-Wen Chang, Yu-Cheng Lin, Chang-Hao Yang. Expression of MicroRNAs in the Eyes of Lewis Rats with Experimental Autoimmune Anterior Uveitis. Mediators Inflamm. 2015 (Published online 2015 Dec 2) [IF: 4.2; SCI 16/183 (33.3%) in Immunology]
43. Wei-Ting Ho, Jung-Shen Chang, Chien-Chia Su, Shu-Wen Chang, Fung-Rong Hu, Tzuu-Shuh Jou, I-Jong Wang. Inhibition of Matrix Metalloproteinase Activity Reverses Corneal Endothelial-Mesenchymal Transition. Am J Pathol. 2015 Aug;185(8):2158-67. [IF: 3.6; SCI 16/90 (17.8%) in Pathology]
44. Tzu-Lun Huang, Chung-Hsing Chang, Shu-Wen Chang, Kung-Hung Lin, Rong-Kung Tsai. Efficacy of Intravitreal Injections of Antivascular Endothelial Growth Factor Agents in a Rat Model of Anterior Ischemic Optic Neuropathy. Invest. Ophthalmol. Vis. Sci. 2015 Apr; 56(4):2290-6. [IF: 4.7; SCI 9/98 (9.2%) in Ophthalmology]
45. Shu-Wen Chang,* Tai-Yuan Su, Yao-Lin Chen. Influence of Ocular Features and Incision Width on Surgically Induced Astigmatism after Cataract Surgery. J. Refract. Surg. 2015 Feb; 31(2):82-8. [IF: 3.0; SCI 48/312 (15.4%) in Surgery]
46. Tzu-Lun Huang, Shun-Ping Huang, Chung-Hsing Chang, Kung-Hung Lin, Shu-Wen Chang, Rong-Kung Tsai. Protective effects of systemic treatment with methylprednisolone in a rodent model of non-arteritic anterior ischemic optic neuropathy (rAION). Exp. Eye Res. 2015 Feb; 131:69-76 [IF: 2.7; SCI 26/98 (26.5%) in Ophthalmology]
47. Tai Yuan Su, Wei Ting Ho, Chien Yi Lu, Shu-Wen Chang*, Huihua Kenny Chiang. Correlations among ocular surface temperature difference value, the tear meniscus height, Schirmer's test and fluorescein tear film break up time. Brit. J. Ophthalmol. 2015 Apr; 99(4):482-7. [IF: 3.5; SCI 15/98 (15.3%) in Ophthalmology]
48. Tai-Yuan Su, Shu-Wen Chang*, Chiao-Ju Yang, and Huihua Kenny Chiang*. Direct observation and validation of fluorescein tear film break-up patterns by using a dual thermal-fluorescent imaging system. Biomed. Opt. Express 2014 Aug;5 (8):2614-9 [IF: 3.2; SCI 51/212 (24.1%) in Radiology, Nuclear Medicine & Imaging]
49. Wei-Ting Ho, Tsan-Chi Chen, San-Fang Chou, Shu-Wen Chang*. Dexamethasone modifies mitomycin C-triggered interleukin-8 secretion in isolated human Tenon's capsule fibroblasts. Exp. Eye Res. 2014 Jul; 124:86-92 [IF: 2.7; SCI 26/98 (26.5%) in Ophthalmology]
50. Wei-Ting Ho, Ting-Hsuan Chiang, Shu-Wen Chang, Yu-Hua Chen, Fung-Rong Hu, I-Jong Wang. Enhanced corneal wound healing with hyaluronic acid and high-potassium artificial tears. Clin. Exp. Optom. 2013 Nov; 96(6):536-41. [IF: 1.5; SCI 59/98 (60.2%) in Ophthalmology]
51. Pei-Yao Chang, Shu-Wen Chang. Corneal Biomechanics, Optic Disc Morphology, and Macular Ganglion Cell Complex in Myopia. J. Glaucoma 2013 Jun-Jul; 22(5):358-62. [IF: 1.8 ; SCI 51/98 (52.0%) in Ophthalmology]
52. Jia-Kang Wang, Shu-Wen Chang. Optical biometry intraocular lens power calculation using different formulas in patients with different axial lengths. Int. Ophthalmol. 2013 Apr; 6(2): 150–4. [IF: 1.4; SCI 61/98 (62.2%) in Ophthalmology]
53. Tsan-Chi Chen, Shu-Wen Chang*, Ting-Yi Wang. Moxifloxacin modifies corneal fibroblast-to-myofibroblast differentiation. Brit. J. Pharmacol. 2013 Mar; 168(6):1341-54 [IF: 7.7; SCI 18/352 (5.1%) in Pharmacology & Pharmacy]
54. Tsan-Chi Chen, Chien-Hsueh Lai, Jie-Ling Chang, Shu-Wen Chang*. Mitomycin C Retardation of Corneal Fibroblast Migration via Sustained Dephosphorylation of Paxillin at Tyrosine 118. Invest. Ophthalmol. Vis. Sci. 2012 Mar; 53(3):1539-47.[IF: 4.7; SCI 9/98 (9.2%) in Ophthalmology]
55. Tai Yuan Su, Chen Kerh Hwa, Po Hsuan Liu, Ming Hong Wu, David O. Chang, Po Fang Su, Shu Wen Chang, and Huihua Kenny Chiang. Noncontact detection of dry eye using a custom designed infrared thermal image system. J. Biomed. Opt. 2011 Apr;16(4):046009. [IF: 2.9; SCI 63/212 (29.7%) in Radiology, Nuclear Medicine & Medical Imaging]
56. San-Fang Chou, Chien-Hsien Lin, Shu-Wen Chang.* Povidone–iodine application induces corneal cell death through fixation. Brit. J. Ophthalmol. 2011 Jan;95(2):277-83. [IF: 3.5; SCI 15/98 (15.3%) in Ophthalmology]
57. Tsan-Chi Chen, Shu-Wen Chang.* Effect of mitomycin C on IL-1R expression, IL-1-related hepatocyte growth factor secretion and corneal epithelial cell migration. Invest. Ophthalmol. Vis. Sci. 2010 Mar; 51(3):1389-96. [IF: 4.7; SCI 9/98 (9.2%) in Ophthalmology]
58. Shu-Wen Chang,* San-Fang Chou, Shuen-Yuen Yu. Dexamethasone reduces mitomycin C-related inflammatory cytokine expression without inducing further cell death in corneal fibroblasts. Wound Repair Regen. 2010 Jan-Feb; 18(1);59-69. [IF: 3.4 ; SCI 19/96 (19.8%) in Dermatology]
59. Pei-Yao Chang, Shu-Wen Chang,* Jiun-Yi Wang. Assessment of corneal biomechanical properties and intraocular pressure with Ocular Response Analyzer in childhood myopia. Brit. J. Ophthalmol. 2010 Jul;94(7):877-81. [IF: 3.5; SCI 15/98 (15.3%) in Ophthalmology]
60. Shu-Wen Chang,* Chin-Yen Yu, Daniel P. Chen. Comparison of intraocular lens power calculation by IOLMaster in phakic and eyes with hydrophobic acrylic lenses. Ophthalmology 2009 Jul; 116(7): 1136-42. [IF: 9.5; SCI 2/98 (2.0%) in Ophthalmology]
61. Chao-Yu Hu, Elsa Mei, Shu-Wen Chang. Widen the anterior chamber angles of a primary angle closure patient with Argon laser peripheral iridoplasty-a case report. Acta Soc. Ophthalmol. Sinicae 2008 47(3): 246-51.
62. Po-Fang Su, Andy Y. Lo, Chao-Yu Hu, Shu-Wen Chang.* Anterior chamber depth measurement in phakic and pseudophakic eyes. Optom. Vis. Sci. 2008 Dec;85(12):1193-200. [IF: 1.8; SCI 51/98 (52.0%) in Ophthalmology]
63. Shu-Wen Chang,* San-Fang Chou, Jia-Ling Chuang. Mitomycin C potentiates ultraviolet-related cytotoxicity in corneal fibroblasts. Cornea. 2008 Jul;27(6):686-92. [IF: 2.1; SCI 40/98 (40.8%) in Ophthalmology]
64. Jia-Kang Wang, Chao-Yu Hu, Shu-Wen Chang. Intraocular lens power calculation using the IOLMaster and various formulas in eyes with long axial length. J. Cataract Refract. Surg. 2008 Feb;34(2):262-7. [IF: 3.2; SCI 44/312 (14.1%) in Surgery]
65. Shu-Wen Chang*, San-Fang Chou, Jia-Ling Chuang. Mechanical corneal epithelium scraping and ethanol treatment up-regulate cytokine gene expression differently in rabbit cornea. J. Refract. Surg. 2008 Feb;24(2):150-9. [IF: 3.0; SCI 48/312 (15.4%) in Surgery]
66. San-Fang Chou, Shu-Wen Chang,* Jia-Ling Chuang. Mitomycin C Upregulates IL-8 and MCP-1 Chemokine Expression via Mitogen-Activated Protein Kinases in Corneal Fibroblasts. Invest. Ophthalmol. Vis. Sci. 2007 May;48(5):2009-16. [IF: 4.7; SCI 9/98 (9.2%) in Ophthalmology]
67. Daniel P. Chen; Shih-Chen Chen; Shu-Wen Chang. Ocular Thelaziasis Manifested As Conjunctivitis –a Case Report. Acta Soc. Ophthalmol. Sinicae. 2007;46(1):46-50.
68. Shu-Wen Chang,* San-Fang Chou, Yao-Horng Wang. Ethanol treatment induces significant cell death in porcine corneal fibroblasts. Cornea. 2006 Oct;25(9):1072-9. [IF: 2.1; SCI 40/98 (40.8%) in Ophthalmology]
69. Shu-Wen Chang,* Zei-Lun Huang. Oral cimetidine adjuvant therapy for recalcitrant, diffuse conjunctival papillomatosis. Cornea. 2006 Jul;25(6):687-90. [IF: 2.1; SCI 40/98 (40.8%) in Ophthalmology]
    Pei-Ching Lai, Jia-Kang Wang, Andy Y. Lo, Shu-Wen Chang. Traumatic Evulasion of the Eyeball: a Case Report. Acta Soc. Ophthalmol. Sinicae. 2006;45(1):30-5.
70. Shu-Wen Chang, Gwo-Jyh Chang, Ming-Jai Su. Change of potassium current density in rabbit corneal epithelial cells during maturation and cellular senescence. J. Formos. Med. Assoc. 2006 Jan;105(1):7-16. [IF: 2.5; SCI 74/332 (22.3%) in Medicine, General & Internal]
71. Shu-Wen Chang,* Yao-Horng Wang; Jong-Hwei Su Pang. The effects of epithelial viability on stromal keratocyte apoptosis in porcine corneas stored in Optisol-GS. Cornea. 2006 Jan;25(1):78-84. [IF: 2.1; SCI 40/98 (40.8%) in Ophthalmology]
72. Wang JK, Lai PC, Yang CM, Chen CH, Chang SW. Circumscribed choroidal hemangioma in a Chinese patient treated using transpupillary thermotherapy: a case report. Kaohsiung J. Med. Sci. 2005;21:433-7. [IF: 3.1; SCI 88/195 (45.1%) in Medicine, Research & Experimental]
73. Shu-Wen Chang.* Corneal keratocyte apoptosis following topical intraoperative mitomycin C in rabbits. J. Refract Surg. 2005 Sep-Oct;21(5):446-53. [IF: 3.0; SCI 48/312 (15.4%) in Surgery]
74. Huang ZL, Chen YF, Chang SW, Lin KK, Hsiao CH. Recurrent Alcaligenes xylosoxidans keratitis. Cornea. 2005 May;24(4):489-90. [IF: 2.1; SCI 40/98 (40.8%) in Ophthalmology]
75. Hung-Chiao Chen, Shu-Wen Chang,* Shiu-Feng Huang. Adjunctive treatment with interferon alpha-2b may decrease the risk of papilloma-associated conjunctival intraepithelial neoplasm recurrence. Cornea 2004 Oct;23(7):726-9. Review. [IF: 2.1; SCI 40/98 (40.8%) in Ophthalmology]
76. Shu-Wen Chang.* Early corneal edema following topical application of mitomycin-C. J. Cataract Refract. Surg. 2004;30(8):1742-50. [IF: 3.2; SCI 44/312 (14.1%) in Surgery]
77. Shu-Wen Chang,* Ai-Chuen Chou, Chang-Hao Yang, Por-Tying Hung. IOL decentration increases with patient’s age. Acta Soc. Ophthalmol. Sinicae, 2003;42:110-9.
78. Wan-Ya Su, Shu-Wen Chang,* Shiu-Feng Huang. Amniotic membrane transplantation for corneal perforation related to vitamin A deficiency. OSLI Retina. 2003 Mar-Apr;34(2):140-4. [IF: 1.1 ; SCI 213/312 (68.3%) in Surgery]
79. Li-Chin Wei, Shu-Wen Chang.* Bilateral retinal hemorrhages following ALK. OSLI Retina. 2002 Jan-Feb;33(1):54-7. [IF: 1.1 ; SCI 213/312 (68.3%) in Surgery]
80. Shu-Wen Chang,* Chee-Jen Chang. Delayed Tear Clearance in Contact Lens Associated Papillary Conjunctivitis. Curr. Eye Res. 2001;22(4):253-7. [IF: 2.0; SCI 44/98 (44.9%) in Ophthalmology]
81. Shu-Wen Chang,* I-Lun Tsai, Fung-Rong Hu, Luke Long-Kuang Lin, Yung-Feng Shih. The corneas in young myopic adults. Brit. J. Ophthalmol. 2001;85(8):916-20. [IF: 3.5; SCI 15/98 (15.3%) in Ophthalmology]
82. Chi-Chin Sun, Shu-Wen Chang, * Ray RF Tsai. Traumatic corneal perforation with epithelial ingrowth after laser in situ keratomileusis. Arch Ophthalmol. 2001 Jun; 119(6):907-9. (JAMA Ophthalmology) [IF: 9.2; SCI 3/98 (3.1%) in Ophthalmology]
83. Shu-Wen Chang,* Fung-Rong Hu, Luke Long-Kuang Lin. Effects of contact lenses on corneal endothelium - a morphological and functional study. Ophthalmologica 2001;215:197-203. [IF: 1.9 ; SCI 47/98 (48.0%) in Ophthalmology]
84. Chang SW,* Ashraf FM, Azar DT.Wound healing patterns following perforation sustained during laser in situ keratomileusis. J. Formos. Med. Assoc. 2000;99(8):635-41. [IF: 2.5; SCI 74/332 (22.3%) in Medicine, General & Internal]
85. Chang SW, Chi RF,Wu CC, Su MJ. Benzalkonium chloride and gentamicin cause a leak in corneal epithelial cell membrane. Exp. Eye Res. 2000 Jul;71(1):3-10.[IF: 2.7; SCI 26/98 (26.5%) in Ophthalmology]
86. Hu FR, Tsai AC,Wang IJ, Chang SW. Outcomes of penetrating keratoplasty with imported donor corneas. Cornea 1999 Mar;18(2):182-7. [IF: 2.1; SCI 40/98 (40.8%) in Ophthalmology]
87. Shu-Wen Chang, Alan Benson, Dimitri T. Azar. Corneal light scattering with stromal reformation after laser in situ keratomileusis and photorefractive keratectomy. J. Cataract Refrac. Surg. 1998;24(8): 1064-9. [IF: 3.2; SCI 44/312 (14.1%) in Surgery]
88. Fung-Rong Hu, Chau-Yi Tan, Shu-Wen Chang, Huai-Wen Chang. Analysis of Corneal TopographyAfter Excimer Laser Photorefractive Keratectomy. J. Formos. Med. Assoc. 1998;97:159-64. [IF: 2.5; SCI 74/332 (22.3%) in Medicine, General & Internal]
89. Yu JH, Hu FR, Chang SW, Wang IJ. Excimer laser photorefractive keratectomy for myopia. J. Formos. Med. Assoc. 1996 Mar;95(3):225-30. [IF: 2.5; SCI 74/332 (22.3%) in Medicine, General & Internal]
90. Shu-Wen Chang,* Fung-Rong Hu, Ping-Kang Hou. Corneal Epithelial Recovery Following Photorefractive Keratectomy. Brit. J. Ophthalmol. 1996;80:663-8.[IF: 3.5; SCI 15/98 (15.3%) in Ophthalmology]
91. An-Chung Tsai, Meng-Chun Tseng, Shu-Wen Chang, Fung-Rong Hu. Clinical Evaluation of Ciprofloxacin Ophthalmic Solution in the Treatment of Refractory Bacterial Keratitis. J. Formos. Med. Assoc. 1995;94:760-4. [IF: 2.6; SCI 70/325 (42.6%) in Medicine, General & Internal]
92. Shu-Wen Chang,* Hui-Chuan Hsu, Fung-Rong Hu, Muh-Shy Chen. Corneal Autofluorescence and Epithelial Barrier Function in Diabetic Patients. Ophthalmic Res. 1995;27:74-9. [IF: 1.9 ; SCI 47/98 (48.0%) in Ophthalmology]
93. Chau-Chung Wu, Shu-Wen Chang, Muh-Shy Chen, Yuan-Teh Lee. Early Change of Vascular Permeability in Hypercholesterolemic Rabbits. Arterioscler. Thromb. Vasc. Biol. 1995 Apr; 15:529-33. [IF: 7.4; SCI 8/98 (8.2%) in Peripheral Vascular Disease]
94. Chen-Kuo Tsen, Shu-Wen Chang, Fung-Rong Hu. Acyclovir Treatment for Linear Corneal Endotheliitis on Grafted Corneas. Cornea.1995;14(3):311-5. [IF: 2.1; SCI 40/98 (40.8%) in Ophthalmology]
95. Shu-Wen Chang,* Fung-Rong Hu. The Epithelial Barrier Function in Clear Corneal Grafts. Ophthalmic Res. 1994;26:283-9. [IF: 1.9 ; SCI 47/98 (48.0%) in Ophthalmology]
96. Hwang Wei-Jen, Fung-Rong Hu, Shu-Wen Chang. Clinicopathologic Study of Gore-Tex Patch Graft in Corneoscleral Surgery. Cornea. 1994;13(1):82-6. [IF: 2.1; SCI 40/98 (40.8%) in Ophthalmology]
97. Shu-Wen Chang,* Meng-Whai Tsai, Fung-Rong Hu. Deep Alternaria Keratomycosis with Intraocular Extension. Am. J. Ophthalmology 117(4):544-5;1994. [IF: 4.2; SCI 12/98 (12.2%) in Ophthalmology]
98. Shu-Wen Chang,* Fung-Fong Hu. Changes in Corneal Autofluorescence and Corneal Epithelial Barrier Function with Aging. Cornea. 12(6):493-9;1993. [IF: 2.1; SCI 40/98 (40.8%) in Ophthalmology]
99. Sanni Chen, Shu-Wen Chang,* Fung-Rong Hu. Ocular Complications in Generalized Erythroderma. Acta Soc. Ophthalmol. Sinicae 1992;31:470-4.
100. Shu-Wen Chang,* Luke Long-Kuang Lin. Study of Refractive Status on Strabismic Patients in Taiwan. Acta Soc. Ophthalmol. Sinicae 1992;31: 236-2.
101. Shu-Wen Chang,* Por-Tying Hung. Effect of carteolol on intraocular pressure elevation following laser iridotomy. J. Clinical. Laser Med. Surg. 1991; Aug: 259-63. (Photobiomodulation Photomedicine and Laser Surgery, 2019 ) [IF: 1.8; SCI 134/312 (42.4%) in Surgery]
102. Shu-Wen Chang,* Ping-Kang Hou, Muh-Shy Chen. Conjunctival Concretions: Polarized Microscopic Histopathologic and Ultrastructural Studies. Arch Ophthalmology 1990 Mar; 108(3):405-7.(JAMA Ophthalmology) [IF: 9.2; SCI 3/98 (3.1%) in Ophthalmology]
103. Shu-Wen Chang,* Muh-Shy Chen, Chu-Fu Lan. Crystalline Tapetoretinal Dystrophy. Acta Soc. Ophthalmol. Sinicae 1989; 28:775-80.